The prevalence of valley fever in 2019 was considerably higher than that reported through national surveillance.

A study published in Epidemiology in late May demonstrated that fine particulate matter in wildfire smoke represents a danger to human health considerably longer than a couple of days as previously ...

Waqar Qureshi, MD, of Baylor College of Medicine, reviews how the approach to diagnosis, management, and patient follow-up has changed since this disease entity was first described in 1955.

Expert Rev Endocrinol Metab. 2008;3(3):349-359. While the findings mentioned are reflective of patient populations in the respective studies, it is worth pointing out again that there is ...

Meloxicam is an enolcarboxamide with preferential COX-2 activity. Studies conducted on experimental models and human tissues indicate that meloxicam is a more potent inhibitor of COX-2 than COX-1 ...

Table 1. Table 1. Common Causes of Disseminated Intravascular Coagulation in Patients With Cancer Infections : Gram-negative bacteria. Meningococcus, Pseudomonas, Salmonella, Haemophilus ...

Rationale for Use . Corticosteroids decrease brain edema. In central nervous system tumors, corticosteroids have been found not only to reduce peritumoral and vasogenic brain edema, but also ...

Metronidazole 500 mg orally twice daily for 7 days, or Metronidazole gel (0.75%), one full applicator (5 g) intravaginally, once daily for 5 days, or Clindamycin cream (2%), one full applicator (5 ...

Sidebar: Key Points. Idiopathic normal pressure hydrocephalus (INPH) is characterized by gait disturbance, cognitive deterioration and urinary incontinence, and is associated with ventricular ...

The most recent advance in shunt valve design is the development of adjustable or programmable valves. [27,28,29,30,31] These valves, which are designed to enable a range of pressure settings from ...

The diagnosis of IBS is determined by certain symptom clusters that "breed true" as a distinct clinical entity. The evidence for and features of these specific symptoms are discussed below. These ...

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...